Physician profile
Derek Vanhille
NPI 1205254885
$791.30
in general payments reported to CMS, 2019-2025
23 companies · $296 in 2025
The $296 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.23 · 2020: $36.25 · 2021: $16.28 · 2022: $98.09 · 2023: $39.82 · 2024: $248 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $103.39 | 2024-2025 | Nucala |
| Inspire Medical Systems, INC. | $75.48 | 2025 | Inspire |
| Genzyme Corporation | $73.76 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $60.69 | 2024-2025 | Dupixent |
| Stryker Corporation | $58.52 | 2019-2022 | |
| Aerin Medical INC. | $50.52 | 2024-2025 | |
| Amgen INC. | $38.01 | 2024-2025 | Tavneos |
| Optinose US, INC. | $36.58 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $28.65 | 2025 | Tezspire |
| Intersect Ent, INC. | $27.86 | 2019-2021 | |
| Acera Surgical, INC. | $25.73 | 2023 | Restrata Wound Matrix |
| Ethicon US, LLC | $25.25 | 2022 | |
| Kaleo, INC. | $23.95 | 2024 | Auvi-Q |
| Bayer Healthcare Pharmaceuticals INC. | $23.81 | 2020 | |
| Carestream Dental, LLC | $21.89 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $19.83 | 2019 | |
| Medtronic, INC. | $17.44 | 2024 | Propel |
| Collegium Pharmaceutical, INC. | $14.27 | 2025 | Jornay Pm |
| Lilly USA, LLC | $14.09 | 2023 | Mounjaro |
| Ge Healthcare | $13.31 | 2019 | |
| Bolder Surgical, LLC | $12.97 | 2022 | |
| Novo Nordisk INC | $12.86 | 2022 | |
| Acclarent, INC | $12.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Vanhille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.